Abstract
The study of hereditary cancer in humans, notably retinoblastoma, has identified a category of cancer genes that is different from that of the oncogenes. Whereas the latter group of genes exerts its effect through expression, the former does so as a result of failure of normal expression. Primary oncogene abnormality seems to play a crucial initiating role in certain neoplasms, particularly leukaemias, lymphomas and some sarcomas. In contrast, anti-oncogenes (tumour suppressor genes) appear to be important in the initiation of several solid tumours of children, as well as some common carcinomas of adults. Both classes are apparently involved in tumour progression and metastasis. Virtually every kind of cancer can occur in hereditary form, so the role of anti-oncogenes in the origin of human cancers may be considerable. The prototypic anti-oncogene has been that for retinoblastoma. For this tumour the recessive mechanism has been demonstrated by molecular means, and the gene has been cloned. The possibility has been suggested that gene (or gene product) replacement therapy could be accomplished.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Presented at the BACR/BIR/RSM Joint Winter Meeting, London, 28–30 November 1988.
Rights and permissions
About this article
Cite this article
Knudson, A. The ninth Gordon Hamilton-Fairley memorial lecture: Hereditary cancers: clues to mechanisms of carcinogenesis. Br J Cancer 59, 661–666 (1989). https://doi.org/10.1038/bjc.1989.137
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.137
This article is cited by
-
The expression of tumour suppressors and proto-oncogenes in tissues susceptible to their hereditary cancers
British Journal of Cancer (2015)
-
Molecular markers and pathogenically targeted therapy in non-small cell lung cancer
Frontiers of Medicine in China (2009)
-
MMTV-induced mutations in mouse mammary tumors: Their potential relevance to human breast cancer
Breast Cancer Research and Treatment (1996)
-
Intervention studies in adenoma patients
World Journal of Surgery (1991)